Hannah M. Cates

Hannah M. Cates

Auto-generated profile, based on publicly available information

Hannah M. Cates

Fishberg Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2017 in Science
Verified
Journal Article
Closed access
PDF file
CPCatherine J. Peña
Catherine J. Peña
HKHope G. Kronman
Hope G. Kronman
DWDeena M Walker
Deena M Walker
HCHannah M. Cates
Hannah M. Cates
RBRosemary C. Bagot
Rosemary C. Bagot
ENEric J Nestler
Eric J Nestler
Early life stress increases risk for depression. Here we establish a “two-hit” stress model in mice wherein stress at a specific postnatal period increases susceptibility to adult social defeat stress and causes long-lasting transcriptional alterations that prime the ventral tegmental area (VTA)—a brain reward region—to be in a depression-like state. We identify a role for the developmental transcription factor orthodenticle homeobox 2 (Otx2) as an upstream mediator of these enduring effects. Transient juvenile—but not adult—knockdown of Otx2 in VTA mimics early life stress by increasing stress susceptibility, whereas its overexpression reverses the effects of early life stress. This work establishes a mechanism by which early life stress encodes lifelong susceptibility to stress via long-lasting transcriptional programming in VTA mediated by Otx2.

1 June 2016 in Neuron
Verified
Journal Article
Closed access
RBRosemary C. Bagot
Rosemary C. Bagot
HCHannah M. Cates
Hannah M. Cates
IPImmanuel Purushothaman
Immanuel Purushothaman
ZLZachary S. Lorsch
Zachary S. Lorsch
DWDeena M. Walker
Deena M. Walker
ENEric J Nestler
Eric J Nestler

8 November 2019 in Nature Communications
Verified
Journal Article
Open access
CPCatherine Jensen Peña
Catherine Jensen Peña
MSMilo Smith
Milo Smith
ARAarthi Ramakrishnan
Aarthi Ramakrishnan
HCHannah M. Cates
Hannah M. Cates
RBRosemary C. Bagot
Rosemary C. Bagot
ENEric J Nestler
Eric J Nestler
Abuse, neglect, and other forms of early life stress (ELS) significantly increase risk for psychiatric disorders including depression. In this study, we show that ELS in a postnatal sensitive period increases sensitivity to adult stress in female mice, consistent with our earlier findings in male mice. We used RNA-sequencing in the ventral tegmental area, nucleus accumbens, and prefrontal cortex of male and female mice to show that adult stress is distinctly represented in the brain’s transcriptome depending on ELS history. We identify: 1) biological pathways disrupted after ELS and associated with increased behavioral stress sensitivity, 2) putative transcriptional regulators of the effect of ELS on adult stress response, and 3) subsets of primed genes specifically associated with latent behavioral changes. We also provide transcriptomic evidence that ELS increases sensitivity to future stress through enhancement of known programs of cortical plasticity.

27 October 2014 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
EHElizabeth A Heller
Elizabeth A Heller
HCHannah M Cates
Hannah M Cates
CPCatherine J Peña
Catherine J Peña
HSHaosheng Sun
Haosheng Sun
Ningyi ShaoNingyi Shao
Ningyi Shao
ENEric J Nestler
Eric J Nestler
The authors selectively modify chromatin in a specific gene in vivo to examine the link between chromatin dynamics and drug- and stress-evoked responses. They report that histone methylation or acetylation at the FosB locus in nucleus accumbens is sufficient to control drug- and stress-evoked transcriptional and behavioral responses. Chronic exposure to drugs of abuse or stress regulates transcription factors, chromatin-modifying enzymes and histone post-translational modifications in discrete brain regions. Given the promiscuity of the enzymes involved, it has not yet been possible to obtain direct causal evidence to implicate the regulation of transcription and consequent behavioral plasticity by chromatin remodeling that occurs at a single gene. We investigated the mechanism linking chromatin dynamics to neurobiological phenomena by applying engineered transcription factors to selectively modify chromatin at a specific mouse gene in vivo. We found that histone methylation or acetylation at the Fosb locus in nucleus accumbens, a brain reward region, was sufficient to control drug- and stress-evoked transcriptional and behavioral responses via interactions with the endogenous transcriptional machinery. This approach allowed us to relate the epigenetic landscape at a given gene directly to regulation of its expression and to its subsequent effects on reward behavior.

22 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
JLJuan Pablo Lopez
Juan Pablo Lopez
LFLaura M. Fiori
Laura M. Fiori
CCCristiana Cruceanu
Cristiana Cruceanu
RLRixing Lin
Rixing Lin
BLBenoit Labonte
Benoit Labonte
GTGustavo Turecki
Gustavo Turecki
Antidepressants (ADs) are the most common treatment for major depressive disorder (MDD). However, only ∼30% of patients experience adequate response after a single AD trial, and this variability remains poorly understood. Here, we investigated microRNAs (miRNAs) as biomarkers of AD response using small RNA-sequencing in paired samples from MDD patients enrolled in a large, randomized placebo-controlled trial of duloxetine collected before and 8 weeks after treatment. Our results revealed differential expression of miR-146a-5p, miR-146b-5p, miR-425-3p and miR-24-3p according to treatment response. These results were replicated in two independent clinical trials of MDD, a well-characterized animal model of depression, and post-mortem human brains. Furthermore, using a combination of bioinformatics, mRNA studies and functional in vitro experiments, we showed significant dysregulation of genes involved in MAPK/Wnt signalling pathways. Together, our results indicate that these miRNAs are consistent markers of treatment response and regulators of the MAPK/Wnt systems.

1 February 2017 in Biological Psychiatry
Verified
Journal Article
Closed access
RBRosemary C. Bagot
Rosemary C. Bagot
HCHannah M. Cates
Hannah M. Cates
IPImmanuel Purushothaman
Immanuel Purushothaman
VVVincent Vialou
Vincent Vialou
EHElizabeth A. Heller
Elizabeth A. Heller
ENEric J Nestler
Eric J Nestler